No title
400 Background: Cells of the tumor microenvironment (TME) have been implicated in prostate cancer (PCa) progression. However, the specific TME cell subtypes and cell–cell interactions driving disease progression in patients remains unclear. Traditional tumor profiling techniques lack the resolution needed to assess complex single-cell and spatial biomarkers. Imaging Mass Cytometry (IMC) can identi
